Group B Medicines AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Object of Procurement

  • What is procured: Concluding a framework agreement for the purchase of Group B medicines. The procurement is divided into 21 lots, covering various medicines (e.g., Clopidogrel, Ticagrelor, Alteplase, Rivaroxaban, Apixaban, Edoxaban, Tranexamic acid, Romiplostim, Ferrum sulfate, Erythropoietin, Alfabepoetin) and one medical solution (Perfusion Solution for Transplantation).
  • Main technical requirements, properties:
    • The offered medicine must have a valid marketing authorization in the Republic of Estonia.
    • The supplier must…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

293605_ESPD_v2.0_laiendatud.xml

293605_hankepass_taiendavate_selgitustega.pdf

293605_hindamiskriteeriumid.pdf

293605_vastavustingimused.pdf

293605.zip

Juhised pakkujale.pdf

Lisa 1.xls

Lisa 2_Raamlepingu projekt.pdf

Lisa_3_Vorm_III_Avaldus.doc

Lisa_3_Vorm II_Volikiri.doc

Lisa 3_Vorm I_Ühispakkujate volikiri.doc

Ready to get started?

Subscribe and enjoy all the benefits every day!